RBFOX3 and stroke disorder: Treatment with either 0.1 or 1 nmol HFI419 beginning at 2 h post-stroke attenuated this loss of NeuN positive staining in the infarcted cortex (375.33 ± 43.62 cells per 0.54 mm2, P < 0.0001 and 263.67 ± 24.18 cells per 0.54 mm2, P < 0.05, respectively) compared to vehicle treated controls (141.43 ± 12.82 cells per 0.54 mm2, Fig. 2B).